A genetically humanized mouse model for hepatitis C virus infection

Nature

Volumn 474, Issue 7350, 2011, Pages 208-212

  Dorner, Marcus ^a   Horwitz, Joshua A ^a   Robbins, Justin B ^b   Barry, Walter T ^a   Feng, Qian ^a   Mu, Kathy ^a   Jones, Christopher T ^a   Schoggins, John W ^a   Catanese, Maria Teresa ^a   Burton, Dennis R ^b,c   Law, Mansun ^b   Rice, Charles M ^a   Ploss, Alexander ^a  

^a ROCKEFELLER UNIVERSITY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

^c MASSACHUSETTS INSTITUTE OF TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SCAVENGER RECEPTOR BI; VACCINIA VACCINE;

DISEASE TREATMENT; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC ENGINEERING; HEPATITIS; IMMUNITY; IMMUNIZATION; INHIBITOR; LIFE CYCLE; PATHOGENICITY; PROTEIN; RECOMBINATION; RODENT; VACCINE; VIRAL DISEASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; GENE EXPRESSION; GENETIC MODEL; HEPATITIS C; HUMAN; HUMORAL IMMUNITY; IMMUNITY; IMMUNIZATION; IMMUNOCOMPETENCE; LIFE CYCLE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; VIRUS ENTRY; VIRUS VIRULENCE;

ADENOVIRIDAE; ANIMALS; ANTIBODIES, BLOCKING; ANTIGENS, CD; CELLS, CULTURED; DISEASE MODELS, ANIMAL; GENOTYPE; HEPACIVIRUS; HEPATITIS C; HEPATOCYTES; HUMANS; IMMUNIZATION, PASSIVE; MEMBRANE PROTEINS; MICE; RECEPTORS, VIRUS; SCAVENGER RECEPTORS, CLASS B; TRANSFECTION; VIRAL TROPISM;

ANIMALIA; HEPATITIS C VIRUS; MURINAE; MUS; RODENTIA; VACCINIA VIRUS;

EID: 79958291149     PISSN: 00280836     EISSN: 14764687     Source Type: Journal    
DOI: 10.1038/nature10168     Document Type: Article

References (35)

1. Pileri, P. et al. Binding of hepatitis C virus to CD81. Science 282, 938-941 (1998). (Pubitemid 28507525)
2. Scarselli, E. et al. The human scavenger receptor class B type I is a novel candidate receptor for the hepatitis C virus. EMBO J. 21, 5017-5025 (2002).
3. Evans, M. J. et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446, 801-805 (2007). (Pubitemid 46582027)
4. Ploss, A. et al. Human occludin is a hepatitis C virus entry factor required for infection of mouse cells. Nature 457, 882-886 (2009).
5. Zhu, Q., Guo, J. T. Seeger, C. Replication of hepatitis C virus subgenomes in nonhepatic epithelial and mouse hepatoma cells. J. Virol. 77, 9204-9210 (2003). (Pubitemid 37011017)
6. Uprichard, S. L., Chung, J., Chisari, F. V. Wakita, T. Replication of a hepatitisCvirus replicon clone in mouse cells. Virol. J. 3, 89 (2006).
7. Chang, K. S. et al. Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities. J. Virol. 80, 7364-7374 (2006).
8. Lin, L. T. et al. Replication of subgenomic hepatitis C virus replicons in mouse fibroblasts is facilitated by deletion of interferon regulatory factor3 and expression of liver-specific microRNA 122. J. Virol. 84, 9170-9180 (2010).
9. McCaffrey, A. P. et al. Determinants of hepatitis C translational initiation in vitro, in cultured cells and mice. Mol. Ther. 5, 676-684 (2002). (Pubitemid 34619060)
10. Schoggins, J. W. et al. A diverse array of gene products are effectors of the type I interferon antiviral response. Nature 472, 481-485 (2011).
11. Safran, M. et al. Mouse reporter strain for noninvasive bioluminescent imaging of cells that have undergone Cre-mediated recombination. Mol. Imaging 2, 297-302 (2003).
12. Awatramani, R., Soriano, P., Mai, J. J. Dymecki, S. An Flp indicator mouse expressing alkaline phosphatase from the ROSA26 locus. Nature Genet. 29, 257-259 (2001). (Pubitemid 33096447)
13. Ploss, A. et al. Persistent hepatitis C virus infection in microscale primary human hepatocyte cultures. Proc. Natl Acad. Sci. USA 107, 3141-3145 (2010).
14. Jones, C. T. et al. Real-timeimaging of hepatitisCvirus infection using a fluorescent cell-based reporter system. Nature Biotechnol. 28, 167-171 (2010).
15. Liang, Y. et al. Visualizing hepatitis C virus infections in human liver by two-photon microscopy. Gastroenterology 137, 1448-1458 (2009).
16. Higginbottom, A. et al. Identification of amino acid residues in CD81 critical for interaction with hepatitisCvirus envelope glycoprotein E2. J. Virol. 74, 3642-3649 (2000). (Pubitemid 30180308)
17. Rigotti, A. et al. A targeted mutation in the murine gene encoding the high density lipoprotein (HDL) receptor scavenger receptor class B type I reveals its key role in HDL metabolism. Proc. Natl Acad. Sci. USA 94, 12610-12615 (1997). (Pubitemid 27492576)
18. Catanese, M. T. et al. High-avidity monoclonal antibodies against the human scavenger class B type I receptor efficiently block hepatitis C virus infection in the presence of high-density lipoprotein. J. Virol. 81, 8063-8071 (2007). (Pubitemid 47101492)
19. Meuleman, P. et al. Anti-CD81 antibodies can prevent a hepatitis C virus infection in vivo. Hepatology 48, 1761-1768 (2008).
20. Law, M. et al. Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge. Nature Med. 14, 25-27 (2008).
21. Youn, J. W. et al. Evidence for protection against chronic hepatitis C virus infection in chimpanzees by immunization with replicating recombinant vaccinia virus. J. Virol. 82, 10896-10905 (2008).
22. Ralston, R. et al. Characterization of hepatitis C virus envelope glycoprotein complexes expressed by recombinant vaccinia viruses. J. Virol. 67, 6753-6761 (1993). (Pubitemid 23309145)
23. Bissig, K. D. et al. Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment. J. Clin. Invest. 120, 924-930 (2010).
24. Mercer, D. F. et al. Hepatitis C virus replication in mice with chimeric human livers. Nature Med. 7, 927-933 (2001). (Pubitemid 32756430)
25. Meuleman, P. et al. Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera. Hepatology 41, 847-856 (2005). (Pubitemid 40462948)
26. de Jong, Y. P., Rice, C. M. Ploss, A.Newhorizons for studying humanhepatotropic infections. J. Clin. Invest. 120, 650-653 (2010).
27. Stoller, J. Z. et al. Cre reporter mouse expressing a nuclear localized fusion of GFP and b-galactosidase reveals new derivatives of Pax3-expressing precursors. Genesis 46, 200-204 (2008). (Pubitemid 351703372)
28. Lindenbach, B. D. et al. Complete replication of hepatitis C virus in cell culture. Science 309, 623-626 (2005). (Pubitemid 41033648)
29. Flint, M. et al. Characterization of hepatitis C virus E2 glycoprotein interaction with a putative cellular receptor, CD81. J. Virol. 73, 6235-6244 (1999). (Pubitemid 29327798)
30. Schoggins, J. W., Gall, J. G. Falck-Pedersen, E. Subgroup B and F fiber chimeras eliminate normal adenovirus type 5 vector transduction in vitro and in vivo. J. Virol. 77, 1039-1048 (2003). (Pubitemid 36055525)
31. Selby, M. et al. Hepatitis C virus envelope glycoprotein E1 originates in the endoplasmic reticulum and requires cytoplasmic processing for presentation by class I MHC molecules. J. Immunol. 162, 669-676 (1999). (Pubitemid 29035385)
32. Cooper, S. et al. Analysis of a successfulimmune response against hepatitisCvirus. Immunity 10, 439-449 (1999). (Pubitemid 29205480)
33. Law, M. Smith, G. L. in Vaccinia Virus and Poxvirology Methods and Protocols Methods in Molecular Biology Series (ed. Isaacs, S. N.) 187-204 (Humana, 2004).
34. Marukian, S. et al. Cell culture-produced hepatitisCvirus doesnot infect peripheral blood mononuclear cells. Hepatology 48, 1843-1850 (2008).
35. Gottwein, J. M. et al. Development and characterization of hepatitis C virus genotype 1-7 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs. Hepatology 49, 364-377 (2009).